Nolvadex 20 - Adelphi Research

Tamoxifen citrate, commonly known as Nolvadex, is a selective estrogen receptor modulator (SERM) widely used in medicine. It was first synthesized in 1962 and introduced for breast cancer treatment after studies confirmed its effectiveness in estrogen-sensitive cancers. Tamoxifen acts by binding to estrogen receptors, blocking estrogen in breast tissue, which helps reduce the risk of recurrence in certain breast cancers. Bodybuilders also use tamoxifen off-label to counter the estrogenic side effects of steroids, such as gynecomastia, by preventing excess estrogen from binding to breast tissue​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Nolvadex 20 by Adelphi Research, consult with your doctor or healthcare professional.